biomarker panel | GenomeWeb

biomarker panel

The company's new blood-based test is the first clinical test offering that the company will be offering at its New York-based CLIA laboratory.

N-of-One will identify the most relevant therapeutic options for each patient tested with Admera's 64-gene oncology panel.

Full-year revenues fell 22 percent, which the company said was due to a decrease in the number of kits being returned for processing. 

The company's recent experience demonstrates the impasse between genetic test developers and payors about the types of clinical evidence needed for coverage.

The companies are co-developing an assay that differentiates previously infected, seropositive Lyme disease patients from newly infected individuals.

OmniSeq's goal is to make cancer genomic testing available to institutions, including comprehensive cancer centers, oncology practices, and community oncology groups.

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

NEW YORK (GenomeWeb) — Data presented earlier this month at the 2014 European League Against Rheumatism (EULAR) Annual Congress by Crescendo Bioscience has added upon earlier retrospective data supporting the clinical utility of the company's Vectra DA test in measuring disease activity and predi

Canada's Prevention of Organ Failure Centre of Excellence in Vancouver is using C$1.5 million (US$1.5 million) in funding from Genome British Columbia and other groups to develop a molecular test intended to personalize treatment for chronic obstructive pulmonary disease.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Foundation Medicine today said that it will partner with Johnson & Johnson Pharmaceutical Research and Development in a biomarker identification collaboration.

Pages

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.